OncoMed Pharmaceuticals Inc·4

Apr 25, 6:13 PM ET

OncoMed Pharmaceuticals Inc 4

4 · OncoMed Pharmaceuticals Inc · Filed Apr 25, 2017

Insider Transaction Report

Form 4
Period: 2017-04-23
Hoey Timothy
SVP, Cancer Biology
Transactions
  • Award

    Common Stock

    2017-04-23+20,00077,225 total
  • Award

    Stock Option (Right to Buy)

    2017-04-23+60,00060,000 total
    Exercise: $3.73Exp: 2027-04-22Common Stock (60,000 underlying)
Footnotes (3)
  • [F1]Restricted stock units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
  • [F2]Includes 32,500 RSUs.
  • [F3]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4